RecruitingNot ApplicableNCT04919980
TVMR With the INNOVALVE System Trial - Early Feasibility Study
Sponsor
Edwards Lifesciences
Enrollment
65 participants
Start Date
Sep 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
Study to evaluate the safety and performance of the INNOVALVE system
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called INNOVALVE system for people with mitral valve regurgitation (degenerative or functional). The study is currently recruiting participants at 20 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEINNOVALVE system
INNOVALVE system
Locations(20)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04919980